Secondary lacrimal atrophy is a condition in which the tear gland shrinks or works poorly, so the eye does not make enough tears. It often causes dry, gritty, burning eyes, blurred vision, and discomfort that can be worse later in the day. Secondary lacrimal atrophy is usually seen in adults and often develops after another problem such as long-term inflammation, autoimmune disease, scarring, surgery, or radiation. Not everyone will have the same experience, but symptoms may last for months or become long term if the gland damage persists. It is not usually life-threatening, and treatment often focuses on relieving dryness with artificial tears, ointments, moisture protection, and care for the underlying cause.
How many people live with Secondary lacrimal atrophy?
Secondary lacrimal atrophy, which means shrinkage of the tear gland caused by another health problem, does not have a well-established worldwide or U.S. population estimate; global and U.S. prevalence estimates are not consistently reported by a single authoritative source. It is usually described as a rare clinical finding linked to other conditions or treatments, rather than counted as a separate diagnosis in major registries or public health reports.
Overview
Secondary lacrimal atrophySymptoms
Secondary lacrimal atrophy often causes dry, gritty, burning eyes, blurred vision, and stringy mucus. Many living with secondary lacrimal atrophy also have redness, light sensitivity, and discomfort that worsens when reading or using screens.
Outlook and prognosis
With secondary lacrimal atrophy, outlook often depends on the underlying cause and how much tear gland function remains. Many can manage dryness with ongoing treatment, though some have lasting dry eye symptoms and need long-term eye care.
Causes and risk factors
Secondary lacrimal atrophy usually results from another problem, especially long-term inflammation, autoimmune disease such as Sjogren syndrome, prior eye-area radiation, surgery, or scarring. Risk rises with older age and conditions that damage or block the tear gland.
Genetic influences
Genetics are usually not a major factor in Secondary lacrimal atrophy. It is more often linked to other eye, immune, treatment, or aging-related causes, though rare inherited conditions can sometimes increase susceptibility.
Diagnosis
Secondary lacrimal atrophy is diagnosed through symptoms, an eye exam, and tear production tests. Doctors may also use imaging or blood tests to look for the cause. The diagnosis of secondary lacrimal atrophy depends on these findings together.
Treatment and drugs
Treatment for Secondary lacrimal atrophy focuses on protecting the eye surface and improving tears. Many use preservative-free artificial tears, lubricating ointment, and sometimes anti-inflammatory eye drops. Doctors also treat the underlying cause and may suggest punctal plugs.
Symptoms
Secondary lacrimal atrophy often shows up as ongoing dry, uncomfortable eyes that do not stay comfortable for long after blinking. In daily routines, this might show up as small but noticeable changes. Many people notice more trouble with reading, screen time, wind, air conditioning, or contact lenses because the eyes are not making enough tears.
Eyes may feel dry, tight, or as if they need more blinking, especially later in the day. Many people use artificial tears often but get only short-lived relief.
There can be a scratchy, sandy feeling, as though something is stuck in the eye when nothing is there. The discomfort often stands out in wind, smoky air, or air-conditioned rooms.
Secondary lacrimal atrophy can cause burning, stinging, or a raw, sore feeling that comes and goes or lingers. The early symptoms of Secondary lacrimal atrophy are easy to mistake for simple irritation or eye strain.
Eyes may feel irritated and also look red or bloodshot. This can become more noticeable after reading, driving, or spending time outdoors.
How people usually first notice Secondary lacrimal atrophy?
People usually first notice secondary lacrimal atrophy when their eyes start feeling persistently dry, gritty, burning, or oddly tired, especially later in the day or in wind, smoke, or air-conditioned rooms. One of the first warning signs of secondary lacrimal atrophy is needing artificial tears more often because the eyes are not making enough of the watery part of tears, which can also lead to redness, blurry vision that clears with blinking, or discomfort with contact lenses. For many people, doctors first suspect it when dry eye symptoms show up alongside another condition that can affect the tear glands, such as autoimmune disease, inflammation, or prior damage to the area.
Types of Secondary lacrimal atrophy
Secondary lacrimal atrophy means the tear gland has become damaged or has shrunk because of another health problem or treatment, so the eye cannot make enough tears. In practice, the main types of Secondary lacrimal atrophy are usually described by the underlying cause, because that often shapes how symptoms feel day to day. Symptoms don’t always look the same for everyone. Many living with Secondary lacrimal atrophy notice dryness, burning, gritty discomfort, and blurred vision that comes and goes, but the pattern can vary.
Autoimmune-related
This type happens when the body’s immune system damages the tear gland over time, as can happen in conditions such as Sjogren disease. Dryness is often steady and significant, and many people also have a dry mouth or other signs of immune system illness.
Inflammatory scarring
Ongoing inflammation from eye or gland disease can leave scar tissue that reduces tear production. Some may find the eye feels sore, irritated, and sensitive to light, especially when the surface of the eye is also inflamed.
Treatment-related
Radiation, surgery, or other medical treatment near the tear gland can lead to Secondary lacrimal atrophy by directly injuring the gland. Symptoms often start after the treatment and may include marked dryness, stringy mucus, and blurry vision that improves for a short time after using artificial tears.
Medication-related
Some medicines can reduce tear production or worsen dryness enough to contribute to this condition, especially in people who already have eye surface problems. Symptoms may be milder at first, with more dryness during reading, screen time, or being in air-conditioned rooms.
Age-associated secondary
In some older adults, tear gland tissue becomes less active and may also be affected by other health conditions, making the atrophy secondary rather than purely age-related dryness. For many, this can mean chronic dry eye symptoms that build gradually and are worse later in the day.
Can I slow down the onset of symptoms?
Usually not in a clearly proven way: with secondary lacrimal atrophy, meaning the tear gland shrinks because of another health problem, there is no strong evidence that diet, supplements, or general lifestyle changes can reliably delay when symptoms start. What seems most helpful is early treatment of the cause, regular eye checkups, treating eye and eyelid inflammation promptly, and avoiding things that can worsen eye damage, such as smoking or ongoing eye irritation; this may help reduce risk of faster worsening, but it does not prevent the condition. Even if you cannot fully stop symptoms from appearing, early care can often help many living with this condition stay more comfortable for longer.
What genetics can tell you about symptoms
For people with secondary lacrimal atrophy, genetics usually does not tell doctors much about which symptoms will happen, because this condition is most often caused by another problem such as inflammation, autoimmune disease, injury, radiation, or certain medicines rather than by a change in a single gene. What matters more is the underlying cause and how much the tear gland has been damaged, which can affect whether dry eyes, burning, irritation, blurry vision, or eye-surface injury are mild or more severe. In some families, inherited conditions that affect immune function or gland development may shape when symptoms begin or how intense they become, but for secondary lacrimal atrophy itself, genetic testing is not usually the main way to predict symptoms.
Causes and risk factors
Dry, gritty eyes from secondary lacrimal atrophy usually happen because another illness or treatment has damaged the tear glands over time. Common causes include autoimmune diseases such as Sjogren syndrome, long term inflammation or infection, radiation to the head or face, and sometimes surgery or injury near the glands. It is rarely just one factor, and the mix often matters. Risk factors for secondary lacrimal atrophy include older age, chronic autoimmune disease, smoking, and past radiation or severe chemical exposure. Family history can add risk by increasing the chance of autoimmune disease, but secondary lacrimal atrophy itself is usually not directly inherited.
What are the most common causes or risk factors?
Secondary lacrimal atrophy usually happens when the tear-making gland slowly shrinks because of another problem, most often long-term inflammation, autoimmune illnesses such as Sjogren disease, aging, or damage after radiation treatment, surgery, injury, or a severe infection. Genetic causes are not usually a main driver, but people with a family tendency toward autoimmune disease may have a higher risk.
Environmental and biological risk factors
Secondary lacrimal atrophy happens when the tear gland becomes smaller after damage from another condition or outside exposure. Many living with secondary lacrimal atrophy first notice persistent dryness, burning, or irritation, while the underlying cause may have been present for some time. Doctors often group risks into internal (biological) and external (environmental). Looking at both helps explain the causes of secondary lacrimal atrophy and who may need a closer eye exam.
Tear glands often lose some reserve with age, especially in later adulthood. This can make the gland more vulnerable to secondary lacrimal atrophy when other injuries or illnesses are present.
Immune conditions that target moisture-producing glands, especially Sjogren syndrome, are a major biological risk. Ongoing immune injury can scar the gland and reduce tear production over time.
Repeated or long-lasting inflammation of the lacrimal gland can slowly damage tear-making tissue. Infection-related inflammation or persistent swelling may leave the gland smaller and less active.
Radiation aimed near the eyes, orbit, face, or head and neck can injure the lacrimal gland. The risk of secondary lacrimal atrophy is higher with larger treatment areas or higher radiation doses, and damage may appear months or years later.
Genetic risk factors
Secondary lacrimal atrophy usually develops because another disease affects the tear gland, so the genetic link is often indirect rather than one single inherited cause. When people ask about the genetic causes of secondary lacrimal atrophy, the key question is whether an inherited syndrome or an inherited tendency to immune disease is present. Carrying a genetic change doesn’t guarantee the condition will appear.
Autoimmune tendency: Inherited immune-system differences can make autoimmune illnesses more likely, especially Sjogren syndrome and sometimes rheumatoid arthritis or lupus. If those illnesses inflame the tear gland for years, they can lead to secondary lacrimal atrophy.
Ectodermal dysplasia: These rare inherited syndromes can affect several body tissues that normally make moisture, including the tear glands. Some people with them have very low tears and long-term dry eye, which can increase the chance of gland shrinkage over time.
Triple A syndrome: This rare genetic condition often causes little or no tear production from early childhood. Over time, poor lacrimal gland function can go along with atrophic changes in some people.
Familial dysautonomia: This inherited nerve disorder can interfere with the body signals that help the eyes make tears. Many living with it have reduced tearing and dry eye, and some may develop secondary lacrimal atrophy over time.
Other rare syndromes: A few other inherited disorders that affect gland development or nerve control can also lower tear production. Doctors may think about these when severe dry eye starts in childhood or appears alongside other body-wide signs.
Lifestyle risk factors
Daily habits can meaningfully affect tear production, ocular surface irritation, and symptom burden in secondary lacrimal atrophy. When people ask about lifestyle risk factors for secondary lacrimal atrophy, the most relevant issues are habits that worsen dryness, inflammation, or tear evaporation rather than habits that directly create the gland damage itself. Consistent self-care can help reduce discomfort and may limit flares of burning, grittiness, blurred vision, and eye fatigue.
Smoking can irritate the ocular surface and promote inflammation that worsens dryness in secondary lacrimal atrophy. It can also make tears less stable, leading to more burning, stinging, and foreign-body sensation.
Long periods of screen use reduce blink frequency and increase tear evaporation. In secondary lacrimal atrophy, this can intensify dryness, blur vision intermittently, and increase eye strain.
Inadequate fluid intake can contribute to a stronger sense of ocular dryness, especially in people who already have reduced tear production. Keeping well hydrated may help symptoms feel less severe, even though it does not reverse gland atrophy.
Diets low in omega-3-rich foods and high in ultra-processed foods may support a more pro-inflammatory state that can aggravate dry eye symptoms. A balanced diet may help how lifestyle affects secondary lacrimal atrophy by supporting tear-film quality and ocular surface comfort.
Risk prevention
Secondary lacrimal atrophy happens when the tear gland becomes damaged over time, so prevention is mostly about lowering the chance of that damage rather than guaranteeing it will not happen. In everyday life, this can mean protecting the eyes from long-term irritation, treating dry eye and eyelid problems early, and managing health conditions that can harm the tear glands. Prevention is flexible—it adapts to your life and health background. If you have ongoing dryness, burning, or gritty eyes, early treatment may help lower the risk of worsening tear gland function.
Long-lasting eye or eyelid inflammation can injure the tear gland over time. Getting blepharitis, conjunctivitis, or autoimmune-related eye inflammation treated early may help reduce the risk of secondary lacrimal atrophy.
Chemical splashes, burns, facial radiation, and repeated eye injury can damage tear-producing tissue. Wearing protective eyewear at work or during risky tasks can help prevent avoidable harm.
Ongoing dry eye can set up a cycle of irritation and surface damage. Using lubricating drops as advised and addressing the cause early may help protect the eye surface and support healthier tear function.
Some medicines can worsen dryness, especially those with drying side effects. Talk to your doctor or pharmacist if your eyes become persistently dry, since adjusting treatment may sometimes lower risk.
Can you prevent Secondary lacrimal atrophy?
Not always. Because secondary lacrimal atrophy happens when the tear-making gland shrinks after another problem, such as long-term swelling, injury, or certain treatments, it usually cannot be fully prevented, but early treatment of the underlying cause and protecting the eyes from damage may lower the risk. Even with good care, some people may still develop it.
Transmission
Secondary lacrimal atrophy can leave the eyes feeling dry, gritty, and easily irritated, but it is not an infectious condition. It cannot be passed from one person to another through touching, coughing, kissing, sharing towels, or close contact.
For many living with secondary lacrimal atrophy, the real issue is the underlying cause, such as another illness, inflammation, injury, surgery, or radiation that has damaged the tear gland. If you are wondering whether secondary lacrimal atrophy is contagious, the answer is no; care usually focuses on finding and treating the problem that led to it.
When to test your genes
Genetic testing is usually not part of early detection or care for secondary lacrimal atrophy, because it is most often acquired rather than inherited. Testing may be worth discussing only if dry eye and gland problems began unusually early, run strongly in your family, or come with other features suggesting a broader inherited syndrome.
Diagnosis
Secondary lacrimal atrophy is usually diagnosed when ongoing dry, irritated eyes lead to a closer look at how well the tear glands are working and whether another condition is damaging them. You might notice small changes in daily routines, like needing eye drops more often, avoiding windy places, or having blurry vision that improves after blinking. Doctors usually begin with an eye exam and questions about symptoms, medicines, autoimmune disease, past infections, radiation, or surgery. The diagnosis of secondary lacrimal atrophy often involves confirming reduced tear production and then finding the underlying cause.
A clinician asks about dry eye symptoms, how long they have been happening, and whether they are getting worse over time. They also review past eye disease, autoimmune conditions, infections, radiation treatment, surgery, and medicines that can reduce tear production.
A detailed eye exam looks for signs of dryness on the surface of the eye, including redness, irritation, and damage to the clear front layer of the eye. The eyelids, tear openings, and nearby glands are also checked to see whether another eye problem could be contributing.
Simple office tests can measure how much tear fluid your eyes make and how stable the tear film is between blinks. These tests help support how secondary lacrimal atrophy is diagnosed and can show whether tear production is lower than expected.
Special dye drops may be placed in the eyes to highlight dry or damaged areas on the eye surface. This helps show how much the dryness is affecting the cornea and surrounding tissues.
How is Secondary lacrimal atrophy diagnosed?
Secondary lacrimal atrophy is usually diagnosed by an eye doctor based on your symptoms, your medical history, and an eye exam that looks for signs that the tear gland is not working well. They often do simple dry-eye tests, such as measuring how much tears your eyes make and checking the eye surface for dryness or damage with special drops and a microscope light. If needed, scans or blood tests may be used to look for the cause, such as past inflammation, radiation treatment, injury, or an autoimmune condition.
Stages of Secondary lacrimal atrophy
Secondary lacrimal atrophy does not have defined progression stages. That is because it is usually described by its cause and by how much tear production has been affected, rather than by a fixed step-by-step pattern over time. Often the process begins when you notice changes in daily life, such as dry, gritty eyes when reading, using screens, or being outside in wind, which can be among the early symptoms of secondary lacrimal atrophy. Doctors usually start with a conversation about symptoms, then check the eyes and tear glands and may use simple tear tests or imaging to monitor how severe the dryness is and whether the underlying cause is changing.
Outlook and prognosis
The outlook for secondary lacrimal atrophy is usually good for overall survival, because it is an eye and gland disorder rather than a life-threatening disease, but the effect on comfort and vision can be long-lasting if dry eye is severe. Prognosis depends mainly on the underlying cause, how much lacrimal gland function remains, and how quickly dryness is recognized and treated. When the cause can be controlled and the ocular surface is protected with lubricants, anti-inflammatory treatment, punctal occlusion, or other supportive care, many people can reduce symptoms and limit damage. If atrophy is advanced or linked to chronic autoimmune disease, radiation, scarring, or longstanding inflammation, tear production may not recover fully and persistent dry eye can lead to recurrent irritation, corneal injury, infection, or visual decline. Mortality is not typically increased by secondary lacrimal atrophy itself, although prognosis may also reflect the seriousness of the disease or treatment that caused it.
Long-term effects
Secondary lacrimal atrophy often affects daily comfort first: eyes may feel dry, gritty, sore, or unusually tired by the end of the day. Over time, the long-term picture is often shaped by how much tear production has been lost and by the underlying cause, such as inflammation, autoimmune disease, surgery, or radiation. For many people, the long-term effects of secondary lacrimal atrophy are mainly ongoing dry eye problems, but some may also develop surface damage to the eye and changes in vision quality.
Secondary lacrimal atrophy often leads to long-lasting dry eye because the tear glands no longer make enough of the watery part of tears. Many living with this notice burning, stinging, grittiness, or a feeling like sand is stuck in the eye.
When the eye stays dry for a long time, the clear front surface can become irritated and injured. This can cause light sensitivity, redness, and tiny scratches that may heal slowly.
Tears help keep vision clear, so poor tear flow can make sight come and go during the day. Reading, computer work, and driving may become harder, especially when symptoms flare.
Ongoing dryness can trigger repeated irritation of the eye surface and eyelids. Some people develop chronic redness, soreness, or mucus that keeps coming back.
How is it to live with Secondary lacrimal atrophy?
Living with secondary lacrimal atrophy often means living with chronic dry eye because the tear glands no longer make enough tears, so your eyes may feel gritty, burning, sore, or unusually tired by the end of the day. For many, this can make reading, driving, screen time, contact lens wear, and being in wind, smoke, or air-conditioned rooms much harder, and symptoms may come and go but often need regular eye drops, moisture protection, and planned breaks. People around you may notice frequent blinking, eye rubbing, light sensitivity, or the need to stop activities early, and family or coworkers sometimes need to understand that this is not just minor irritation but an ongoing condition that can affect comfort, focus, and daily routines.
Treatment and drugs
Treatment for Secondary lacrimal atrophy usually focuses on two things at once: treating the problem that damaged the tear gland and relieving dry, irritated eyes. Depending on the cause, this may mean managing an autoimmune condition, reducing inflammation, changing a medicine that is worsening dryness, or treating damage from surgery, radiation, or injury. For many people, treatment begins with small daily steps, such as using artificial tears during the day, lubricating ointment at night, and sometimes prescription eye drops that calm inflammation and help the eye surface heal. If dryness remains severe, an eye specialist may suggest tiny plugs to slow tear drainage or other office-based treatments, and many living with Secondary lacrimal atrophy need ongoing follow-up because what works today may need adjustment later.
Can you cure Secondary lacrimal atrophy?
There is not usually a simple cure for secondary lacrimal atrophy, which means the tear glands have been damaged or have shrunk because of another health problem or treatment. Care is aimed at treating the cause when possible and easing dry eye symptoms with options like artificial tears, eye ointments, warm compresses, or other treatments an eye doctor may suggest. If the gland damage is severe, treatment can still improve comfort and protect the eyes, but it may not fully bring tear production back to normal.
Non-drug treatment
Secondary lacrimal atrophy can make everyday tasks like reading, driving, or using a computer uncomfortable because the eyes do not stay moist enough. For many, treatment begins not at the pharmacy, but with steps that protect the eye surface, reduce tear loss, and make better use of the tears you still produce. Non-drug treatments may be recommended alone or alongside treatment for the underlying cause, such as autoimmune disease, prior radiation, or gland injury. Not every approach works the same way, so many living with secondary lacrimal atrophy need a mix of strategies.
Gentle warmth on the closed eyelids can help the oily glands in the lids work better, so tears evaporate more slowly. This may ease burning, grittiness, and blurred vision that tends to come and go.
Cleaning the eyelid margins can lower irritation from debris, crusting, or mild lid inflammation. Keeping the lids healthy often helps the tear film stay more stable.
Long stretches of reading or screen use can reduce blinking and make dryness worse. Simple routines—like blinking fully and taking regular breaks—can have lasting benefits for eye comfort.
Humidifiers, avoiding direct fans, and wearing wraparound or moisture chamber glasses can reduce tear loss into the air. These steps can be especially helpful indoors, on airplanes, or in dry climates.
Your genes may have an impact on how drugs work for you
For people with secondary lacrimal atrophy, treatment usually focuses on easing dry eye symptoms and treating the underlying cause, and there is no well-established evidence that inherited genetic differences strongly change how the usual eye medicines work. In day-to-day life, this means most people are treated based on their symptoms, exam findings, and how their eyes respond over time, rather than on a genetic test. Even so, many living with this condition may react differently to drops or other treatments because of factors like age, other health problems, and the cause of the gland damage, so care is often adjusted step by step.
Pharmacological treatments
With secondary lacrimal atrophy, treatment usually focuses on easing dry, irritated eyes and managing the condition that damaged the tear gland in the first place. Medicines do not usually regrow the gland, but they can improve comfort, protect the eye surface, and lower inflammation. Some medicines work quickly, while others take weeks to help. If symptoms are severe, an eye specialist may combine several treatments over time.
Lubricating eye drops such as carboxymethylcellulose, hypromellose, glycerin, or sodium hyaluronate are often the first medicines used for secondary lacrimal atrophy. They replace moisture for a short time and can help with burning, grittiness, and blurred vision that comes and goes.
Thicker lubricants such as carbomer gel or petrolatum-mineral oil eye ointment can last longer than regular drops. Many living with secondary lacrimal atrophy use them at bedtime because they may blur vision for a while.
Cyclosporine eye drops, including 0.05% and higher-strength forms in some regions, help calm inflammation that reduces tear production. They are often used long term, and it may take several weeks to notice improvement.
Lifitegrast is a prescription eye drop that lowers inflammation linked to dry eye symptoms. It may help with discomfort and eye surface damage, including in people with early symptoms of secondary lacrimal atrophy-related dry eye.
Genetic influences
Secondary lacrimal atrophy is usually not caused by a single inherited gene change. In most cases, the tear gland becomes smaller after another problem, such as long-term inflammation, an autoimmune illness, injury, surgery, or radiation treatment, so the genetic link is often indirect rather than the main cause. It’s natural to ask whether family history plays a role, and for some people it may, because some of the conditions that can lead to secondary lacrimal atrophy can cluster in families. This means family history may raise risk, but it does not mean someone will definitely develop secondary lacrimal atrophy. If early symptoms of secondary lacrimal atrophy appear alongside dry eye or autoimmune problems in several relatives, a doctor can help decide whether a closer look at family history, and only occasionally genetic testing, would be helpful.
Is Secondary lacrimal atrophy genetic?
Genetics are usually not a major factor in Secondary lacrimal atrophy. It is more often linked to other eye, immune, treatment, or aging-related causes, though rare inherited conditions can sometimes increase susceptibility.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal part of being human and are common in the general population. Most of these variants do not have a direct effect on health and are simply part of natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When dry, burning eyes keep coming back, many living with secondary lacrimal atrophy wonder why one treatment plan helps more than another. Many people ask whether genetic testing helps treatment for secondary lacrimal atrophy, and right now it is not part of routine care for choosing lubricating drops, tear-preserving treatment, or prescription anti-inflammatory eye medicines. Genetics is only one factor: doctors usually get more useful guidance from the cause of the tear gland damage, how much tear function is left, other eye surface problems, and whether another medicine is contributing to dryness. Genes may still matter indirectly, because inherited differences can raise the chance of autoimmune or inflammatory illnesses that damage the tear glands, and for a few systemic medicines used to treat those illnesses, genetic testing may sometimes help with dosing or side effect risk. For most people with secondary lacrimal atrophy, treatment is tailored mainly to symptoms, eye exam findings, and the underlying cause rather than to a gene test.
Interactions with other conditions
Secondary lacrimal atrophy often does not happen on its own, and many people with it are also dealing with another health problem that has damaged or scarred the tear gland. Doctors call it a comorbidity when two conditions occur together. Common linked conditions include autoimmune illnesses such as Sjogren disease, long-term inflammatory disorders, past eye or facial infections, and diseases that affect the eyelids or eye surface, all of which can make dry eye symptoms worse. For many living with secondary lacrimal atrophy, this can mean burning, blurred vision, or a gritty feeling becomes more noticeable when another condition is active or poorly controlled. People with diabetes, thyroid eye disease, or skin conditions that affect the eyelids may also have more irritation because the eye already has less protection from tears. Treatment usually works best when doctors look beyond the eye itself and also manage the underlying disease, since that often has a big effect on the early symptoms of secondary lacrimal atrophy and how severe they become over time.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Secondary lacrimal atrophy?
Other common causes of the same dry, gritty, burning eye symptoms include regular dry eye linked to aging, long screen time, air conditioning, contact lenses, or medicines such as antihistamines and some antidepressants. Doctors also often consider problems with the tiny oil glands in the eyelids, eye allergies, and immune system conditions such as Sjogren disease, because these can also make the eyes feel very dry and irritated.
History
People living with secondary lacrimal atrophy often come to medical care because everyday things start to feel harder: reading may lead to burning eyes, wind can sting, and contact lenses may become difficult to tolerate. The condition has been recognized gradually, not as one single disease at first, but as a later change in the tear-producing gland after inflammation, scarring, autoimmune illness, radiation, surgery, or other damage.
In older medical writings, doctors described severe eye dryness and irritation long before they could directly study the lacrimal gland in detail. Early observers mostly focused on what they could see and what people reported, such as gritty discomfort, redness, and damage to the surface of the eye. Only later did physicians connect these symptoms to shrinkage or loss of function in the gland that normally helps make tears.
As medical science evolved, better microscopes, eye staining tests, and tissue studies made it clearer that the lacrimal gland could be injured over time by other conditions rather than being abnormal from birth. That shift mattered. It helped doctors separate secondary lacrimal atrophy from other causes of dry eye and from problems affecting the eyelids, tear drainage system, or the eye surface itself.
During the 20th century, doctors learned more from people with autoimmune diseases, chronic inflammation, and treatment-related gland damage. In these groups, clinicians began to notice a pattern: the gland could become inflamed, then scarred, and eventually less able to produce tears. For many, this can mean symptoms that creep up slowly over months or years rather than appearing all at once.
Modern imaging and laboratory research have refined that picture further. Doctors can now assess tear production more directly and, in some cases, look at structural changes in the lacrimal gland itself. This has improved how secondary lacrimal atrophy is identified, especially when the early symptoms of secondary lacrimal atrophy overlap with more common dry eye problems.
Today, the history of secondary lacrimal atrophy is really the story of a symptom complex that became better understood over time. What once seemed like a vague form of “dry eye” is now recognized as a possible downstream effect of other medical problems or prior damage to the tear gland. That clearer understanding has helped guide more targeted care, with attention not only to easing dryness but also to finding and treating the underlying cause when possible.